Trial Profile
A Study to Evaluate the Efficacy of Telaprevir + Peginterferon-alfa-2b + Ribavirin in Patients with Chronic hepatitis C Virus (HCV) Genotype 1b Infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Ribavirin (Primary) ; Telaprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms AG & RGT
- 17 Dec 2015 New trial record